Glyburide As Treatment Option in Decreasing Intracranial Pressure Associated with Idiopathic Intracranial Hypertension. (P2.211)

CONCLUSION: Glyburide has been shown to decrease intracranial pressure in acute ischemic strokes both in animal studies and early human clinical trials by blocking SURI-1-sodium channel receptors. This is the first time the effectiveness of Glyburide has been documented in patients with IIH. Further studies are needed to evaluate the effectiveness of Glyburide in decreasing cerebral spine fluid pressure in intracranial idiopathic hypertension.Disclosure: Dr. Ahad has nothing to disclose. Dr. Ahmed has nothing to disclose. Dr. Ahmed has nothing to disclose.
Source: Neurology - Category: Neurology Authors: Tags: Headache: Therapeutics Source Type: research